Profile picture

Professor Adnan Kastrati

German Heart Center Muenchen Technical University of Munich, Munich (Germany)
Membership: FESC Member
Follow
Biography
Received his medical degree from the University of Tirana, Albania and completed his training in Cardiology in the University Hospital Center, Tirana, Albania. Completed fellowships in Interventional Cardiology at the University of Heidelberg and Technical University of Munich, Germany. Designed and conducted a large number of randomized clinical trials, mostly identifiable by the “ISAR”-acronym. Wrote or contributed to more than 800 original publications. His interests focus is on reperfusion strategies in acute myocardial infarction, evaluation of new device technologies in interventional cardiology, peri-interventional antithrombotic therapy and genetics in cardiovascular medicine. Received Sven-Effert-Award (2009) and the Paul Morawitz Award (2015) from the German Society of Cardiology. He is also the recipient of The ETHICA Award (2014) from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the Andreas Grüntzig Award (2014) (2014) from the ESC.
Logo ESC

Contributor content

Diabetes and coronary artery disease
Session
Diabetes and coronary artery disease
31 August 2025
Meet the Gold Medallist - Roxana Mehran
Session
Meet the Gold Medallist - Roxana Mehran
29 August 2025
Microvascular dysfunction in chronic coronary syndromes
Session
Microvascular dysfunction in chronic coronary syndromes
29 August 2025
Percutaneous coronary intervention and outcomes
Session
Percutaneous coronary intervention and outcomes
27 August 2022
Coronary complications and how to fix them
Session
Coronary complications and how to fix them
30 August 2021
Highlights from the Young in emerging cardiovascular interventions
Session
Highlights from the Young in emerging cardiovascular interventions
27 August 2021
Atrial fibrillation in the context of acute coronary syndromes and coronary intervention: what should we do?
Session
Atrial fibrillation in the context of acute coronary syndromes and coronary intervention: what should we do?
28 August 2018
Meet the trialist - GLOBAL LEADERS TRIAL - A randomized comparison of 24 month ticagrelor and 1 month aspirin versus 12 month dual antiplatelet therapy followed by aspirin monotherapy
Session
Meet the trialist - GLOBAL LEADERS TRIAL - A randomized comparison of 24 month ticagrelor and 1 month aspirin versus 12 month dual antiplatelet therapy followed by aspirin monotherapy
27 August 2018
NSTEMI - I came, I diagnosed, I treated
Session
NSTEMI - I came, I diagnosed, I treated
29 August 2016

ESC 365 is supported by